|
Volumn 23, Issue 11, 2000, Pages 1605-1611
|
Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: A 6-month randomized placebo-controlled dose-response study
|
Author keywords
[No Author keywords available]
|
Indexed keywords
C PEPTIDE;
HEMOGLOBIN A1C;
PIOGLITAZONE;
PLACEBO;
ADULT;
AGED;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIABETES CONTROL;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GLUCOSE BLOOD LEVEL;
GLUCOSE METABOLISM;
HUMAN;
HYPERGLYCEMIA;
INSULIN RESISTANCE;
LIPID BLOOD LEVEL;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
RANDOMIZED CONTROLLED TRIAL;
RISK BENEFIT ANALYSIS;
|
EID: 0033754530
PISSN: 01495992
EISSN: None
Source Type: Journal
DOI: 10.2337/diacare.23.11.1605 Document Type: Article |
Times cited : (609)
|
References (20)
|